Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Sherlock Biosciences Appoints Maurice Exner as Chief Scientific Officer
Sherlock Biosciences, a company engineering biology to bring next-generation diagnostics to the point-of-need, today announced that […]
Ginkgo Bioworks and WARF Announce Partnership to Discover Next Generation GD2 CAR T-Cell Therapies
The Wisconsin Alumni Research Foundation (WARF), which has a mission of supporting research at the University […]
Visus Therapeutics Appoints Ophthalmology Industry Expert Jehan Tamboowalla to Senior Vice President of Business Development and Marketing
Visus Therapeutics, a clinical-stage biopharmaceutical company focused on developing multi-targeted ophthalmic therapeutics for the front […]
Novo Holdings Invests in US$105 Million Series C Funding of Alentis Therapeutics
Novo Holdings A/S, a leading international life sciences investor, today announced it has participated in […]
Agathos Biologics Launches Analytical Services
Agathos Biologics, a leading biotechnology company, is proud to offer advanced analytical testing services for […]
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Standigm Announces Younsung Choo as Chief Executive Officer (CEO)
Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, announced that Younsung […]
Geneos Therapeutics Secures $5 Million in Series A3 Financing
Geneos Therapeutics, a clinical-stage biotherapeutics company focused on the development of personalized therapeutic cancer vaccines […]
Collective Health Announces Appointment of Dr. Linda Grais to Board of Directors
Collective Health has announced the addition of Dr Linda Grais, a seasoned physician and biopharma […]
VintaBio Unveils $64M to Back Viral Vector Trailblazers Behind the First Approved Cell and Gene Therapies
VintaBio, a life sciences company with unmatched industry expertise helping alleviate the viral vector bottleneck […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more